Wordt geladen...
Characterization and Prognostic Significance of Cutaneous Adverse Events to Anti-Programmed Cell Death-1 Therapy
BACKGROUND: Anti-programmed cell death-1 (PD-1) immunotherapy using antibodies such as nivolumab or pembrolizumab has shown promise for treating various types of cancer. In this study, we reviewed the frequency and spectrum of cutaneous adverse events (AEs) caused by PD-1 antibodies and their possib...
Bewaard in:
| Gepubliceerd in: | J Korean Med Sci |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The Korean Academy of Medical Sciences
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609422/ https://ncbi.nlm.nih.gov/pubmed/31269545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2019.34.e186 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|